EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Epithelial–mesenchymal plasticity in breast cancer: from cell states to clinical vulnerability

Tingjie Yuan, Jean Paul Thiery, Klaus Pantel, Daniel J Smit

Trends in Cancer · 2026

DOI: 10.1016/j.trecan.2026.04.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2026. Verfasst von Tingjie Yuan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg 20246, Germany. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Hamburg-Eppendorf, ERC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial-mesenchymal transition (EMT) in breast cancer is better understood as epithelial-mesenchymal plasticity (EMP), a dynamic and reversible spectrum of epithelial, hybrid, and mesenchymal states. In this review, we discuss how EMP is deployed differently across hormone receptor-positive/HER2-negative, HER2-positive, and triple-negative/claudin-low breast cancers, with distinct implications for metastasis, immune evasion, liquid biopsy, and therapeutic resistance. We highlight the regulatory networks and microenvironmental cues that shape state transitions and emphasize that hybrid and plasticity-high states may be more clinically informative than terminal mesenchymal states alone. We propose that progress will depend on subtype-aware, biomarker-guided strategies that resolve carcinoma cell state in space and time and therapeutically exploit EMT-associated vulnerabilities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionBreast NeoplasmsHumansFemaleTumor MicroenvironmentBiomarkers, TumorDrug Resistance, NeoplasmErb-b2 Receptor Tyrosine KinasesNeoplastic Cells, CirculatingAnimalsTumor Escape

Stichwörter der Autor:innen

breast cancerbreast cancer subtypescirculating tumor cellsepithelial–mesenchymal plasticityimmune evasiontherapeutic resistance

Substanzen

Biomarkers, TumorErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg 20246, Germany.
  • Nabi CNRS 8175, INSERM 1334, Université Paris Cité, Paris 75006, France.
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg 20246, Germany. Electronic address: pantel@uke.de.
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg 20246, Germany. Electronic address: d.smit@uke.de.

Förderung

  • Universitätsklinikum Hamburg-Eppendorf
  • ERC

Zitieren

APA

Yuan, T., Thiery, J. P., Pantel, K., & Smit, D. J. (2026). Epithelial–mesenchymal plasticity in breast cancer: from cell states to clinical vulnerability. Trends in Cancer. https://doi.org/10.1016/j.trecan.2026.04.008

Vancouver

Yuan T, Thiery JP, Pantel K, Smit DJ. Epithelial–mesenchymal plasticity in breast cancer: from cell states to clinical vulnerability. Trends in Cancer. 2026. doi:10.1016/j.trecan.2026.04.008

BibTeX
@article{Yuan2026,
  author = {Yuan, Tingjie and Thiery, Jean Paul and Pantel, Klaus and Smit, Daniel J},
  title = {Epithelial–mesenchymal plasticity in breast cancer: from cell states to clinical vulnerability},
  journal = {Trends in Cancer},
  year = {2026},
  doi = {10.1016/j.trecan.2026.04.008}
}
Kostenlos starten →